2002
DOI: 10.1016/s0920-9964(01)00330-9
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance imaging of the thalamus in male patients with schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
19
0
1

Year Published

2004
2004
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(24 citation statements)
references
References 38 publications
3
19
0
1
Order By: Relevance
“…r Coscia et al r r 1242 r verges with a volumetric MR imaging study reporting greater right compared with left thalamus volume in male schizophrenia patients [Deicken et al, 2002]. Similarly, our results are consistent with a recent study [Kovalev et al, 2003] investigating sex effects on brain asymmetry in a cohort of 380 healthy adults.…”
Section: Discussionsupporting
confidence: 91%
“…r Coscia et al r r 1242 r verges with a volumetric MR imaging study reporting greater right compared with left thalamus volume in male schizophrenia patients [Deicken et al, 2002]. Similarly, our results are consistent with a recent study [Kovalev et al, 2003] investigating sex effects on brain asymmetry in a cohort of 380 healthy adults.…”
Section: Discussionsupporting
confidence: 91%
“…Though previous studies reported that the volume of thalamus could be modulated under anti-psychotic drug treatment from as early as weeks (Dazzan et al 2005) to several years (Gur et al 1998a;van Haren et al 2007), most of them focused on the effects of typical and atypical agents rather than the timing of this modulation occur. Atypical anti-psychotic treatments were reported to be particularly associated with the thalami enlargement (Dazzan et al 2005) (Scherk and Falkai 2006), while other studies have found reduced thalamic volume in chronic patients treated from typical to Olanzapine (Khorram et al 2006) or failed to detect significant thalamic volume change in medicated schizophrenic patients (Deicken et al 2002). However, Lewis and Lieberman contend that different anti-psychotic drugs appear to perform more similarly than previously thought (Leucht et al 2009(Leucht et al , 2003.…”
Section: Neuroplasticity Induced By Anti-psychotic Drugsmentioning
confidence: 98%
“…Thalamic pathology has not been a universal finding in schizophrenia. Several in vivo imaging and postmortem studies have failed to find abnormalities in thalamic volume or neuronal number in schizophrenic subjects (Portas et al, 1998;Arciniegas et al, 1999;Deicken et al, 2002;Cullen et al, 2003;Dorph-Petersen et al, 2004;Preuss et al, 2005). Moreover, recent neuroimaging analyses of the hippocampus (Csernansky et al, 2002) and thalamus (Csernansky et al, 2004) in the same cohort of schizophrenic subjects has indicated that pathology of one or the other structure may be more pronounced in different individuals (Csernansky, personal communication).…”
Section: Comparable Cell Number In Schizophrenic and Control Subjectsmentioning
confidence: 99%
“…In addition, postmortem studies of brains from schizophrenic subjects have reported a reduction in total neuronal number and volume of individual thalamic nuclei, e.g., the mediodorsal, anterior, pulvinar and ventral lateral posterior nuclei (Pakkenberg, 1990;Popken et al, 2000;Young et al, 2000;Byne et al, 2002;Danos et al, 2002;. It should be noted, however, that several studies have not found evidence of thalamic pathology in schizophrenic subjects (Portas et al, 1998;Arciniegas et al, 1999;Deicken et al, 2002;Cullen et al, 2003;Dorph-Petersen et al, 2004;Preuss et al, 2005). Moreover, all of the thalamic nuclei that have been implicated in schizophrenia are reciprocally connected with higher association cortices; therefore, it is not clear whether thalamic neuronal deficits in schizophrenia extend to sensory thalamic nuclei, such as the LGN.…”
Section: Introductionmentioning
confidence: 99%